Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 28, 2022
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapyAnthony T Reder, Olaf Stuve, Stephanie K Tankou, et al.
Scientific Reports|August 30, 2019
Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitorsCarlos G Gonzalez, Stephanie K Tankou, Laura M Cox, et al.
Cell Host & Microbe|December 1, 2019
Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphilaShirong Liu, Rafael M Rezende, Thais G Moreira, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2018
Investigation of probiotics in multiple sclerosisStephanie K Tankou, Keren Regev, Brian C Healy, et al.
Iscience|November 2, 2023
Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAEPaola Bianchimano, Kacper Iwanowski, Emma M Smith, et al.
Microbiome|October 17, 2022
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosisPaola Bianchimano, Graham J Britton, David S Wallach, et al.
Annals of Neurology|April 22, 2018
A probiotic modulates the microbiome and immunity in multiple sclerosisStephanie K Tankou, Keren Regev, Brian C Healy, et al.
Nature Cell Biology|June 14, 2005
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 bindingMakoto R Hara, Nishant Agrawal, Sangwon F Kim, et al.
Annals of Neurology|April 20, 2021
Gut Microbiome in Progressive Multiple SclerosisLaura M Cox, Amir Hadi Maghzi, Shirong Liu, et al.
Pageof 2